NPD StriVectin report
This article was originally published in The Rose Sheet
StriVectin-SD sales in U.S. department stores were $30 mil. during the first five months of 2004, though fewer than 5% of women are aware of the anti-aging and stretch mark cream, and only 12% of those own it, NPD Group reports in "Beyond Botox: Understanding the StriVectin-SD Consumer," released July 19. Klein-Becker's StriVectin originally launched in health food stores as a stretch mark treatment, but approximately 75% of buyers use the product to fight facial lines and wrinkles, market research firm says. Since its department store debut last May, StriVectin "has become an important player in the prestige skin care industry," NPD notes, adding the formula "has managed to surpass blockbuster prestige skin care products in terms of dollar volume"...
You may also be interested in...
Klein-Becker's signature statement for StriVectin-SD anti-aging cream - "Better than Botox?" - constitutes a structure/function claim that would require the product to be regulated as a drug, the agency states in a 1warning letter recently posted on its Web site
Beiersdorf and former owner Bayer are on the verge of settling a proposed class action in California’s Northern District challenging “mineral-based” claims on Coppertone sunscreens that also contain chemical UV filters. However, the parties will have to try again with their proposed terms.
The MHRA is in listening mode as it gathers feedback to shape the UKCA marking for medical devices. See what Phil Brown, regulatory director of the Association of British HealthTech Industries, said about it here.